NASDAQ:ENDP - Endo International Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $6.60
  • Forecasted Upside: 13.21 %
  • Number of Analysts: 6
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
▼ -0.22 (-3.64%)

This chart shows the closing price for ENDP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Endo International Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ENDP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ENDP

Analyst Price Target is $6.60
▲ +13.21% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Endo International in the last 3 months. The average price target is $6.60, with a high forecast of $11.00 and a low forecast of $3.00. The average price target represents a 13.21% upside from the last price of $5.83.

This chart shows the closing price for ENDP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 6 polled investment analysts is to hold stock in Endo International. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 2 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 2 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 2 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 2 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/31/2021Piper SandlerDowngradeOverweight ➝ Neutral$10.00 ➝ $3.00Medium
8/9/2021Royal Bank of CanadaLower Price TargetSector Perform$6.00 ➝ $5.00Medium
5/17/2021CitigroupBoost Price TargetBuy$10.00 ➝ $11.00Low
4/7/2021Royal Bank of CanadaInitiated CoverageSector Perform$7.00High
3/8/2021BarclaysBoost Price TargetPositive ➝ Equal Weight$6.00 ➝ $7.00High
3/4/2021CitigroupLower Price Target$11.00 ➝ $10.00High
3/3/2021Morgan StanleyBoost Price TargetUnderweight$5.00 ➝ $7.00High
2/8/2021SVB LeerinkReiterated RatingMarket PerformLow
1/19/2021CitigroupBoost Price Target$7.00 ➝ $9.00High
1/4/2021Piper SandlerBoost Price TargetOverweight$6.00 ➝ $12.00N/A
11/12/2020Morgan StanleyBoost Price TargetUnderweight$3.00 ➝ $4.00Medium
10/9/2020Piper SandlerBoost Price TargetOverweight$5.00 ➝ $6.00High
7/27/2020The Goldman Sachs GroupInitiated CoverageSell$3.00High
7/8/2020SunTrust BanksReiterated RatingBuyHigh
6/11/2020Royal Bank of CanadaReiterated RatingHold$6.00Medium
5/10/2020Royal Bank of CanadaReiterated RatingHold$6.00Low
4/24/2020CitigroupInitiated CoverageBuy$7.00High
4/15/2020Piper SandlerLower Price TargetOverweight$7.00 ➝ $6.00Medium
4/2/2020Royal Bank of CanadaReiterated RatingHold$6.00Low
4/2/2020Morgan StanleyLower Price TargetUnderweight$4.00 ➝ $3.00Low
1/3/2020Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$5.00 ➝ $7.00Low
8/9/2019Morgan StanleySet Price TargetSell$2.00N/A
8/8/2019Royal Bank of CanadaReiterated RatingHold$6.00High
8/7/2019MizuhoReiterated RatingHold$6.00High
7/31/2019MizuhoReiterated RatingHold$6.00High
7/15/2019Morgan StanleyDowngradeEqual Weight ➝ Underweight$8.00 ➝ $3.00Medium
7/11/2019Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$11.00 ➝ $6.00High
6/17/2019CitigroupDowngradeBuy ➝ Neutral$19.00 ➝ $5.00Medium
6/12/2019Cantor FitzgeraldLower Price TargetNeutral$18.00 ➝ $4.75High
6/11/2019BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$6.00High
5/15/2019Canaccord GenuityLower Price TargetBuy$17.00 ➝ $15.00Low
5/14/2019MizuhoSet Price TargetHold$9.00Low
5/13/2019JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$9.00High
3/27/2019GabelliReiterated RatingHoldMedium
3/19/2019SunTrust BanksInitiated CoverageBuy ➝ Buy$13.00Medium
3/18/2019JPMorgan Chase & Co.Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00Low
3/8/2019Canaccord GenuitySet Price TargetBuy$17.00Low
3/5/2019SVB LeerinkDowngradeOutperform ➝ Market PerformLow
3/1/2019Piper Jaffray CompaniesReiterated RatingHoldHigh
11/26/2018MizuhoLower Price TargetNeutral$15.00High
11/9/2018Canaccord GenuityUpgradeHold ➝ Buy$16.00 ➝ $20.00Low
11/9/2018CowenReiterated RatingHold$9.00Low
10/19/2018Cantor FitzgeraldBoost Price TargetNeutral ➝ Neutral$12.00 ➝ $18.00Low
9/11/2018The Goldman Sachs GroupUpgradeSell ➝ Neutral$14.00 ➝ $15.00Low
8/17/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$7.00 ➝ $17.00Low
8/14/2018MizuhoBoost Price TargetNeutral$17.00Low
8/13/2018Canaccord GenuityReiterated RatingHold ➝ Hold$13.00Low
8/13/2018Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$26.00High
8/10/2018BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$9.00 ➝ $16.00Low
8/9/2018SVB LeerinkBoost Price TargetOutperform ➝ Market Perform$12.00 ➝ $18.00High
8/9/2018Stifel NicolausBoost Price TargetHold ➝ Hold$10.00 ➝ $17.00Low
8/9/2018CitigroupBoost Price TargetBuy ➝ Buy$11.00 ➝ $19.00Low
8/8/2018Cantor FitzgeraldSet Price TargetHold$12.00High
8/7/2018B. RileyBoost Price TargetBuy ➝ Buy$13.00 ➝ $15.00Low
8/1/2018Canaccord GenuitySet Price TargetHold$13.00Low
7/23/2018Cantor FitzgeraldSet Price TargetHold$12.00Medium
7/18/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$11.00Low
7/11/2018CitigroupReiterated RatingBuyLow
6/28/2018B. RileyBoost Price TargetBuy ➝ Buy$10.00 ➝ $13.00High
6/27/2018CitigroupUpgradeNeutral ➝ Buy$11.00High
6/1/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$10.00Medium
5/13/2018OppenheimerReiterated RatingHoldLow
5/8/2018Canaccord GenuitySet Price TargetHold$7.00Low
5/8/2018Cantor FitzgeraldSet Price TargetHold$7.00High
4/4/2018MizuhoDowngradeBuy ➝ Neutral$12.00 ➝ $7.00High
3/10/2018BarclaysSet Price TargetHold$9.00Low
3/5/2018BMO Capital MarketsLower Price TargetMarket Perform ➝ Market Perform$10.00 ➝ $9.00High
2/28/2018GabelliDowngradeBuy ➝ HoldHigh
2/27/2018OppenheimerReiterated RatingHoldHigh
2/27/2018Canaccord GenuitySet Price TargetHold$7.00High
2/27/2018Cantor FitzgeraldSet Price TargetHold$7.00Low
2/26/2018JMP SecuritiesDowngradeOutperform ➝ Market PerformLow
2/23/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$15.00 ➝ $10.00High
2/21/2018Canaccord GenuitySet Price TargetHold ➝ Hold$8.00 ➝ $7.00Medium
2/14/2018B. RileyInitiated CoverageBuy ➝ Buy$10.00High
1/11/2018Cantor FitzgeraldSet Price TargetHold$7.00Low
1/3/2018MizuhoReiterated RatingBuy ➝ Buy$14.00 ➝ $12.00High
1/2/2018SVB LeerinkInitiated CoverageOutperform ➝ Outperform$12.00High
12/12/2017GuggenheimInitiated CoverageNeutral ➝ Neutral$8.50Low
11/10/2017Piper Jaffray CompaniesReiterated RatingHold$7.00N/A
11/10/2017MizuhoReiterated RatingBuyN/A
11/10/2017BMO Capital MarketsLower Price TargetMarket Perform$11.00 ➝ $10.00N/A
11/10/2017Cantor FitzgeraldLower Price TargetNeutral$9.00 ➝ $7.00N/A
11/10/2017CitigroupLower Price TargetNeutral$9.00 ➝ $7.00N/A
11/10/2017Royal Bank of CanadaLower Price TargetSector Perform ➝ Sector Perform$9.00 ➝ $8.00N/A
10/30/2017Cantor FitzgeraldSet Price TargetHold$9.00N/A
10/17/2017Royal Bank of CanadaSet Price TargetHold$9.00N/A
9/28/2017The Goldman Sachs GroupInitiated CoverageSell ➝ Sell$7.00High
9/17/2017Piper Jaffray CompaniesReiterated RatingHold$9.00Medium
9/12/2017MizuhoReiterated RatingBuy$19.00 ➝ $14.00Low
8/14/2017Canaccord GenuitySet Price TargetHold$10.00High
8/11/2017BMO Capital MarketsReiterated RatingMarket Perform$15.00 ➝ $11.00Low
8/10/2017Morgan StanleyLower Price TargetEqual Weight$12.00 ➝ $8.00Low
8/10/2017CowenReiterated RatingHold$16.00High
8/10/2017CitigroupReiterated RatingNeutral$14.00 ➝ $11.00High
8/10/2017MizuhoReiterated RatingBuy$19.00High
8/10/2017Royal Bank of CanadaSet Price TargetHold$15.00 ➝ $9.00High
8/9/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$15.00 ➝ $13.00Low
8/9/2017Royal Bank of CanadaReiterated RatingSector Perform$15.00 ➝ $9.00High
8/8/2017OppenheimerReiterated RatingHoldHigh
8/8/2017Cantor FitzgeraldSet Price TargetHold$12.00 ➝ $9.00Medium
7/23/2017OppenheimerReiterated RatingHoldHigh
7/16/2017Royal Bank of CanadaSet Price TargetHold$15.00Medium
7/7/2017Deutsche Bank AktiengesellschaftLower Price TargetBuy$18.00 ➝ $15.00Medium
6/17/2017GuggenheimInitiated CoverageHold$12.00Medium
6/16/2017Cantor FitzgeraldInitiated CoverageNeutral ➝ Neutral$12.00Low
6/14/2017William BlairReiterated RatingMarket PerformLow
6/12/2017Royal Bank of CanadaSet Price TargetHold$15.00Low
6/9/2017Stifel NicolausDowngradeBuy ➝ Hold$22.00 ➝ $15.00High
6/8/2017OppenheimerReiterated RatingHoldHigh
6/8/2017Canaccord GenuitySet Price TargetHold$14.00 ➝ $12.00High
5/25/2017MizuhoReiterated RatingBuy ➝ Buy$18.00 ➝ $19.00Low
5/22/2017Canaccord GenuitySet Price TargetHold$14.00High
5/17/2017BMO Capital MarketsReiterated RatingHold$16.00High
5/11/2017Canaccord GenuitySet Price TargetHold$14.00Medium
5/1/2017Canaccord GenuitySet Price TargetHold$14.00Low
5/1/2017BMO Capital MarketsReiterated RatingHold$15.00Low
4/17/2017Canaccord GenuityReiterated RatingHold$14.00Low
4/13/2017MizuhoReiterated RatingBuy$17.00 ➝ $18.00Low
4/11/2017Canaccord GenuityReiterated RatingHold$14.00High
4/8/2017Royal Bank of CanadaSet Price TargetHold$15.00Medium
3/20/2017SVB LeerinkReiterated RatingMarket PerformLow
3/15/2017JMP SecuritiesReiterated RatingOutperform$20.00High
3/15/2017Royal Bank of CanadaReiterated RatingSector Perform$15.00High
3/14/2017Canaccord GenuitySet Price TargetHold$14.00High
3/11/2017William BlairReiterated RatingMarket PerformN/A
3/3/2017MizuhoBoost Price Target$17.00N/A
3/1/2017OppenheimerReiterated RatingHoldN/A
3/1/2017Canaccord GenuitySet Price TargetHold$14.00N/A
2/28/2017MizuhoReiterated RatingBuy$15.00 ➝ $17.00N/A
2/28/2017GuggenheimReiterated RatingBuy$35.00N/A
2/21/2017Canaccord GenuityInitiated CoverageHold ➝ Hold$14.00N/A
2/6/2017BarclaysLower Price TargetEqual Weight$22.00 ➝ $15.00N/A
1/31/2017Susquehanna BancsharesUpgradeNeutral ➝ PositiveN/A
1/31/2017MizuhoLower Price TargetBuy$25.00 ➝ $15.00N/A
1/30/2017Royal Bank of CanadaReiterated RatingSector Perform$18.00 ➝ $15.00N/A
1/27/2017Piper Jaffray CompaniesSet Price TargetHold$12.00N/A
1/20/2017JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$20.00N/A
1/5/2017CitigroupDowngradeBuy ➝ Neutral$25.00 ➝ $20.00N/A
12/11/2016JMP SecuritiesReiterated RatingOutperform$34.00N/A
12/7/2016OppenheimerReiterated RatingMarket PerformN/A
(Data available from 11/28/2016 forward)

News Sentiment Rating

0.47 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 2 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
  • 1 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
  • 3 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 12 very positive mentions
  • 23 positive mentions
  • 5 negative mentions
  • 0 very negative mentions

Current Sentiment

  • 12 very positive mentions
  • 23 positive mentions
  • 5 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Endo International logo
Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment conducts certain manufacturing, quality assurance, R&D and administration functions. The Generic Pharmaceuticals segment conducts certain manufacturing, distribution, quality assurance and administration functions, as well as certain R&D functions. The International Pharmaceuticals segment's operations are currently conducted through Paladin's leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.
Read More

Today's Range

Now: $5.83
Low: $5.70
High: $5.91

50 Day Range

MA: $4.69
Low: $2.74
High: $6.76

52 Week Range

Now: $5.83
Low: $1.94
High: $10.89


3,547,849 shs

Average Volume

6,665,291 shs

Market Capitalization

$1.36 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Endo International?

The following Wall Street research analysts have issued reports on Endo International in the last twelve months: Barclays PLC, Citigroup Inc., Morgan Stanley, Piper Sandler, Royal Bank of Canada, SVB Leerink LLC, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for ENDP.

What is the current price target for Endo International?

5 Wall Street analysts have set twelve-month price targets for Endo International in the last year. Their average twelve-month price target is $6.60, suggesting a possible upside of 13.2%. Citigroup Inc. has the highest price target set, predicting ENDP will reach $11.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $3.00 for Endo International in the next year.
View the latest price targets for ENDP.

What is the current consensus analyst rating for Endo International?

Endo International currently has 1 sell rating, 4 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ENDP, but not buy more shares or sell existing shares.
View the latest ratings for ENDP.

How do I contact Endo International's investor relations team?

Endo International's physical mailing address is First Floor Minerva House Simmonscourt Road Ballsbridge, Dublin L2, 19355. The company's listed phone number is (531) 268-2000 and its investor relations email address is [email protected] The official website for Endo International is